Blogs about: Novartis

Featured Blog

Novartis Acknowledges Employees Participated In 'Independent' Trials

Larry Husten wrote 2 days ago: Novartis has acknowledged that employees of the company participated in five “independent … more →

Tags: People Places Events, Policy & Ethics, clinical trial, Japan, scientific misdconduct, valsartan

Survey Says: Metastatic Breast Cancer Can Be a Lonely Experience5 comments

MBCNbuzz wrote 3 days ago: By Katherine O’Brien, MBCN Secretary “Jennie” was diagnosed with a metastatic recu … more →

Tags: media, Conference, MBCN, metastatic breast cancer, MBCN conference, count us, Know Us, Join Us

Women with advanced breast cancer feel left out of the breast cancer movement - new survey shows

wapsmedia wrote 4 days ago: A new global survey sponsored by Novartis Oncology of nearly 1,300 women in 12 countries finds that … more →

Tags: Africa, health, Oncology, American Cancer Society, Femama

A victory for global public health in the Indian, Ellen T Hoen

donttradeourlivesaway wrote 4 days ago: Source: Journal of Public Health Policy Abstract On 1 April of this year, the Indian Supreme Court u … more →

Tags: generic drug, Sec 3 (d), IP Rights, Patent, Novartis Case, Access to medicines, imatinib, Indian Patent office, Supreme Court of India

Novartis wins GBCHealth Business Action on Health Award for social ventures initiative

wapsmedia wrote 1 week ago: Novartis is pleased to announce that GBCHealth, a coalition of more than 230 private sector companie … more →

Tags: Africa, health, Africa 2, Arogya Parivar, India, switzerland

Honesty is The Best Policy2 comments

buildingpharmabrands wrote 1 week ago: What is the best business policy? Honesty of course. Because the cost of hiding the truth can be ver … more →

Tags: Product Management, Pharma Sales Management, Strategic Planning, advertising, Regulatory, copy writing, Sanofi-Aventis, Abbott, Pfizer

Scandale #Distilbène: rares sont les professionnels de la santé qui s'intéressent vraiment au DES

DES Daughter wrote 1 week ago: Un combat de David contre Goliath… Lorsque l’écrivaine Marie Darrieussecq, fille Distilb … more →

Tags: Women's Health, health news, France, marie darrieussecq, distilbène, UCB Pharma

* India: Patents and precedents

keeper @ chindia-alert wrote 1 week ago: FT: “Pharmaceutical companies fear that the battle raging in India over patents will inspire o … more →

Tags: India alert, Economics, Health, intellectual property rights, pharma economics, New Delhi, India, Pfizer, Bristol-Myers Squibb

India: Patents and precedents

donttradeourlivesaway wrote 1 week ago: Source:Financial Times May 15,2013 Pharmaceutical companies fear that the battle raging in India ove … more →

Tags: generic drug, drug pricing, Sec 3 (d), IP Rights, Patent, Novartis Case, Access to medicines, Intellectual Property, united states

Analysis of Pharma Engagement on Twitter – Pfizer, Sanofi and Novartis lead the race2 comments

Payel Guhathakurta @Value Edge wrote 1 week ago: While Pfizer leads in followers, Sanofi US leads the way # of tweets and Novartis leads in engagemen … more →

Tags: social media insights, twitter, Pfizer, SANOFI, Boehringer Ingelheim

Alert: fake antimalarial drugs in circulation

GHN wrote 1 week ago: The Food and Drugs Authority (FDA), has warned that there are some fake Coartem tablets in circulati … more →

Tags: Ghana, Food and Drug Administration, coartem

Real-world data at ARVO highlight transformational outcomes seen with Lucentis®, including lower injection frequency than in original clinical trials.

zedie wrote 1 week ago:     UK real world study shows 59% reduction of legal blindness attributable to wet AMD since in … more →

Tags: Medicine, News, Macular Degeneration, lucentis, united states, ranibizumab, Advanced Micro Devices, AMD, DM&E

Kevin Rigby's 2013 Honorable Mentor speech

Carol Meerschaert wrote 1 week ago: Kevin RigbyHBA 2013 Honorable Mentor Good afternoon everyone! David, thank you for those generous re … more →

Tags: HBA Awards, woman of the year, Pharma, Career, Healthcare Businesswomen's Association, life sciences, WOTY, Awards, Kevin Rigby

Bridgette Heller's 2013 HBA Woman of the Year speech

Carol Meerschaert wrote 1 week ago: Bridgette HellerHBA’s 2013 WOTY Thank you, Ken, for that very kind introduction. I am deeply h … more →

Tags: Healthcare, Healthcare Businesswomen's Association, hba, WOTY, HBA Rising Stars, Merck, Bridgette Heller, Girls Inc., serven leader

Social Media Analysis - Tecfidera mostly gaining patients switching from Copaxone and Tysabri

Geet Sethi@ Value Edge wrote 1 week ago: In the previous blog we commented on the definite positive buzz around Tecfidera and the large no. o … more →

Tags: social media insights, Biogen Idec, Tecfidera, BG 12, tysabri, Copaxone, Multiple Sclerosis, Merck Serono, Sanofi-Aventis

Social Media Analysis - Biogen Idec's Tecfidera mounts popularity charts

Geet Sethi@ Value Edge wrote 1 week ago: It has been nearly 6 weeks since the FDA approved Biogen Idec’s Tecfidera and since then the discuss … more →

Tags: social media insights, Biogen Idec, Tecfidera, BG 12, tysabri, Copaxone, Multiple Sclerosis, Sanofi-Aventis, Aubagio

Gleevec: New Book On The Journey Of Discovery

Orphan Druganaut Blog wrote 1 week ago: The book. “The Philadelphia Chromosome: A Mutant Gene and the Quest to Cure Cancer at the Genetic Le … more →

Tags: orphan drug development, chronic myelogenous leukemia. CML, Rare Diseases, rare disease, orphan drugs, Orphan drug, gleevec

Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis.

zedie wrote 1 week ago: Ilaris® (canakinumab) is the first interleukin-1 beta inhibitor for the treatment of SJIA and the on … more →

Tags: Medicine, News, canakinumab, clinical trial, cryopyrin associated periodic syndrome, Food and Drug Administration, ilaris, Juvenile idiopathic arthritis, Sjia

Zephaniah 1, Romans 8:20-21 and Hosea 4 coming to pass1 comment

arkofgod wrote 2 weeks ago: 3000 fish retrieved AROUND 3000 dead, rotting fish were retrieved from the Vasse estuary at Wonnerup … more →

Tags: Sign Of Times, european union, influenza vaccine, protein sciences, Paul Needham, Flublok, FDA, Food and Drug Administration, Guillain-Barre Syndrome


Related Tags
All →

Follow this tag via RSS